Abstract
1. Butyrylperazine was administered to 20 patients at Manhattan State Hospital, New York City, and 26 patients at the University Psychiatric Clinic of Erlangen, West Germany. 2. There were significant differences between both groups in (a) dosage requirements, (b) side effects, and (c) clinical results. 3. It is suggested that genetic factors may play some role in explaining at least two of these findings (2a and b).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
